title: The LMCE1 unselected group of stage IV neuroblastoma revisited with a median follow up of 59 months after ABMT.
authors.affiliation: Bone Marrow Transplant Department, Centre L. Bérard, Lyon, France.
authors.forename: T
authors.initials: T
authors.lastname: Philip
authors.forename: J M
authors.initials: JM
authors.lastname: Zucker
authors.forename: J L
authors.initials: JL
authors.lastname: Bernard
authors.forename: P
authors.initials: P
authors.lastname: Lutz
authors.forename: P
authors.initials: P
authors.lastname: Bordigoni
authors.forename: E
authors.initials: E
authors.lastname: Plouvier
authors.forename: A
authors.initials: A
authors.lastname: Robert
authors.forename: H
authors.initials: H
authors.lastname: Roché
authors.forename: G
authors.initials: G
authors.lastname: Souillet
authors.forename: E
authors.initials: E
authors.lastname: Bouffet
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D009447:Neuroblastoma / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*; D012074:Remission Induction; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous